Adalimumab treatment of resistant chondrocalcinosis Fatih Tastekin, Kenan Aksu

Necrotizing fasciitis in a patient receiving tocilizumab for rheumatoid arthritis – Case report Diana Rosa-Gonçalves, Miguel Bernardes, Lúcia Costa

A cost-consequence analysis of the preferential use of secukinumab versus adalimumab for the treatment of psoriatic arthritis Alberto Jiménez-Morales, Rafael Cáliz, Susana Aceituno, Miriam Prades, Carles Blanch